High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CNC, VLO, and LCUT it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 2nd, 2026.
On August 31, Centene Corporation (NYSE:CNC) named Bradley Bolivar its new Chief Information Officer, taking over from Brian LeClaire, who plans to retire by the end of October 2026. Bolivar arrives with nearly three decades of technology leadership, most recently as CIO of Fannie Mae, where his portfolio spanned application development, infrastructure, cybersecurity, data and […]
Oscar Health has surged 109% YTD as membership, revenue and expansion plans strengthen, though its price-to-book multiple tops the industry average.
CNC's Marketplace recovery is boosting profitability as better pricing, medical cost trends and risk dynamics reshape its earnings outlook.
Consensus knocks a quarter off the health insurer's earnings multiple over two years, part of it measurement, and almost none of it from selling more coverage.
Bradley Bolivar is taking the reins of Centene’s IT strategy as artificial intelligence drives a sea change for how insurers do business.
CNC, VLO, and MNDY it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 31, 2026.
The healthcare giant sent a fortune back to its owners, but the market yawned. Here’s the real accounting of what that cash bought, and what it didn't.
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MOH's contract wins, acquisitions and cash generation support growth, but elevated medical costs and valuation pose risks.
COCO, DAR, CNC, EXC and AMRX offer a defensive appeal as consumer confidence hits a 7-month low amid inflation and labor market concerns.
CNC, ENS and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 27th, 2026.
Centene's assessed fair value has shifted from US$63.78 to US$71.67, a move that signals a higher valuation framework in current models. Recent analyst commentary connects these higher targets to expectations for cleaner margins, steadier earnings quality and a more supportive view of capital returns, even as Medicaid exposure and policy risk remain key watch points. As you read on, you will see how to track this evolving Centene story and what to watch as the narrative changes over...
HUM benefits from Medicare Advantage growth, CenterWell expansion and strong cash generation, but rising costs and debt remain concerns.
Low P/B stocks Invesco, Centene, Hewlett Packard Enterprise, Gibraltar Industries and Avnet combine value with growth potential.
Centene, Archer-Daniels-Midland, Avnet, Arrow and AMN have been highlighted in this Screen of The Week article.
CNC, ADM, AVT, ARW and AMN emerge from a broker-focused screen as Iran-U.S. tensions, rising oil prices and rate uncertainty cloud markets.
CNC, ENS and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 25th, 2026.
UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.
An aging U.S. population, digital transformation, a diversified membership mix and strategic M&A are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
The healthcare giant is wrestling with costs in one part of its business, and the stock's recent dip has investors wondering if this is the moment to step in.
EHC's rising demand, higher patient acuity and hospital expansion support growth, while rising expenses and debt remain key risks.
Centene Corporation recently announced that long-serving CFO Drew Asher will step down from his role at the end of 2026, with former Lincoln Financial executive Chris Neczypor set to join in September and assume the Executive Vice President and Chief Financial Officer position on January 1, 2027. The planned overlap between Asher and Neczypor, following a period in which Centene’s revenue grew from about US$126.00 billion in 2021 to about US$195.00 billion in 2025, highlights an emphasis on...
Aon expects U.S. employer health-care costs to rise 9.5% in 2027, intensifying pressure on benefits budgets and demand for cost-management services.
CNC, ENS and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 21st, 2026.
A rate hike could keep markets volatile, making BVS, CNC, AMRX and CRON healthcare stocks to consider as inflation stays elevated.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 27.5% gain over the past six months, beating the S&P 500 by 16.2 percentage points.
CI's growth and shareholder returns are weighed against rising costs, medical expenses and debt, keeping investors neutral for now.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
